If you are still having problems viewing this message, please click here for additional help.

Welcome to OncoNotes, a bimonthly e-newsletter from Memorial Sloan-Kettering Cancer Center that provides physicians with news and information about advances in cancer prevention, treatment and research, clinical trials, and upcoming CME programs.

For additional information about Memorial Sloan-Kettering Cancer Center, please visit our Web site at http://www.mskcc.org. We welcome your comments and questions about OncoNotes. Please e-mail us at OncoNotes@mskcc.org.

Experimental Breast Cancer Drug Shows Promise in Aggressive Form of Disease
Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against triple-negative breast cancer (TNBC), one of the most aggressive forms of the disease.

Investigational Treatment Shows Early Promise Against Metastatic Melanoma
Preliminary findings from a study led by Memorial Sloan-Kettering investigators have revealed rapid and dramatic shrinking of metastatic tumors in patients treated with a new compound that interrupts a tumor-growth pathway present in the majority of patients with melanoma.

Online CME Programs
Memorial Sloan-Kettering Cancer Center offers free online CME activities for physicians.

Updated Prediction Tools
Researchers at Memorial Sloan-Kettering Cancer Center have pioneered the use of computerized prediction models to help patients and their physicians decide among the major treatment choices for several cancers. Enhanced versions of nomograms for the following cancers are now available: bladder, gastric carcinoma, melanoma, and sarcoma.

E-Newsletter Survey
Several weeks ago you were emailed a brief survey on what type of oncology news and information you would find valuable in a physician e-newsletter.

If you have already completed this survey, thank you for your input. If you have not yet responded, please click here. Your answers will help us provide content that is relevant and useful to you in your practice.

This e-mail powered by Med-E-Mail connects physicians with relevant commercial messages germane to the practice of medicine.
If you wish to no longer receive messages from this sender please review your preference page here.